<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS104046</article-id>
<article-id pub-id-type="doi">10.1101/2020.11.09.372201</article-id>
<article-id pub-id-type="archive">PPR236733</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The hydroalcoholic extract of <italic>Uncaria tomentosa</italic> (Cat’s claw) inhibits the replication of novel coronavirus (SARS-CoV-2) <italic>in vitro</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yepes-Perez</surname>
<given-names>Andres F.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herrera-Calderón</surname>
<given-names>Oscar</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Flórez-Álvarez</surname>
<given-names>Lizdany</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zapata-Cardona</surname>
<given-names>María I.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yepes</surname>
<given-names>Lina</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aguilar</surname>
<given-names>Wbeimar</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rugeles</surname>
<given-names>María T.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zapata</surname>
<given-names>Wildeman</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Chemistry of Colombian Plants, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia-UdeA, Calle 70 No. 52-21, A.A 1226, Medellin, Colombia</aff>
<aff id="A2">
<label>b</label>Academic Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Jr Puno 1002, Lima 15001, Peru</aff>
<aff id="A3">
<label>c</label>Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín, Colombia</aff>
<aff id="A4">
<label>d</label>Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín, Colombia</aff>
<author-notes>
<corresp id="CR1">
<bold>Corresponding author.</bold> Jr. Puno 1002, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima 15001, Peru. Tel.: + 51 9 56 550 510. <email>oherreraca@unmsm.edu.pe</email>.</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>11</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>10</day>
<month>11</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
<license license-type="open-access" xlink:href="https://europepmc.org/downloads/openaccess">
<license-p>This preprint is made available via the <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/downloads/openaccess">Europe PMC open access subset</ext-link>, for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original preprint source.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">The coronavirus disease 2019 (COVID-19) has become a serious problem for public health since it was identified in the province of Wuhan (China) and spread around the world producing high mortality rates and economic losses. Nowadays, WHO recognizes traditional, complementary, and alternative medicine for treating COVID-19 symptoms. Therefore, we investigated the antiviral potential of the hydroalcoholic extract of <italic>Uncaria tomentosa</italic> stem bark from Peru against SARS-CoV-2 <italic>in vitro</italic>. The antiviral activity of <italic>U. tomentosa</italic> against SARS-CoV-2 <italic>in vitro</italic> was assessed in Vero E6 cells using cytopathic effect (CPE) and plaque reduction assay. After 48h of treatment, <italic>U. tomentosa</italic> showed an inhibition of 92.7 % of SARS-CoV-2 at 25.0 µg/mL (p&lt;0.0001) by plaque reduction assay on Vero E6 cells. In addition, <italic>U. tomentosa</italic>, induced a reduction of 98.6 % (p=0.02) and 92.7 % (p=0.03) in the CPE caused by SARS-CoV-2 on Vero E6 cells at 25 µg/mL and 12.5 µg/mL, respectively. The EC<sub>50</sub> calculated for <italic>U. tomentosa</italic> extract by plaque reduction assay was 6.6 µg/mL (4.89 – 8.85 µg/mL) for a selectivity index of 4.1. The EC<sub>50</sub> calculated for <italic>U. tomentosa</italic> extract by TCID<sub>50</sub> assay was 2.57 µg/mL (1.05 – 3.75 µg/mL) for a selectivity index of 10.54. These results showed that <italic>U. tomentosa</italic> known as Cat’s claw has antiviral effect against SARS-CoV-2 observed as a reduction in the viral titer and CPE after 48h of treatment on Vero E6 cells. Therefore, we hypothesized that <italic>U. tomentosa</italic> stem bark, could be promissory to the development of new therapeutic strategies against SARS-CoV-2.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Uncaria tomentosa</italic>, Cat’s claw</kwd>
<kwd>Antivirals</kwd>
<kwd>Coronavirus</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>COVID-19</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P2">The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused serious public health problems since it was identified in Wuhan (China) in late 2019 [<xref ref-type="bibr" rid="R1">1</xref>]. The World Health Organization (WHO) declared Coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020 [<xref ref-type="bibr" rid="R2">2</xref>]. According to the latest report of the WHO, over 40,2 million cases and 1,100,000 deaths by COVID-19 were confirmed to October 20, 2020 [<xref ref-type="bibr" rid="R3">3</xref>]. When, the novel coronavirus (SARS-CoV-2) arrived to Latin-America, Brazil was the first South American country to declare a patient with COVID-19 whereas Venezuela and Uruguay were the ultimate nations to confirm their patient zero considering the pandemic epicenter after Europe [<xref ref-type="bibr" rid="R4">4</xref>]. Although some vaccines phase 3 medical trials are being tested in different countries sponsored by the pharmaceutical industry, currently, there is no vaccines, preventive treatment or antiviral drug available against SARS-CoV-2 [<xref ref-type="bibr" rid="R5">5</xref>].</p>
<p id="P3">Nowadays, the World Health Organization (WHO) recognizes that traditional, complementary, and alternative medicine has many benefits [<xref ref-type="bibr" rid="R6">6</xref>]. Several candidates with possible antiviral effects have been explored from medicinal plants in the preclinical phase. <italic>Uncaria tomentosa</italic> (Willd) DC., (<italic>U. tomentosa</italic>) belongs to Rubiaceae family, which is also known as Cat’s claw, it contains more than 50 phytochemicals [<xref ref-type="bibr" rid="R7">7</xref>]. Oxindole alkaloids (pentacyclic oxindole alkaloids (POA) and tetracyclic oxindole alkaloids (TOA)) have been recognized as fingerprint of this species in some pharmacopeias and several pharmacological activities are linked to this kind of alkaloids [<xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref>]. It has been demonstrated that <italic>Uncaria tomentosa</italic> (<italic>U. tomentosa</italic>) exerts an antiviral effect on human monocytes infected with dengue virus 2 (DENV-2) [<xref ref-type="bibr" rid="R10">10</xref>] and herpes simplex virus type 1 (HSV-1) [<xref ref-type="bibr" rid="R11">11</xref>]. In our previous studies <italic>in silico, U. tomentosa’s</italic> components inhibited the SARS-CoV-2 enzyme 3CL<sup>pro</sup> and disrupted the interface of the receptor-binding domain of angiotensin-converting enzyme 2 (RBD–ACE-2) as well as the SARS-CoV-2 spike glycoprotein [<xref ref-type="bibr" rid="R12">12</xref>,<xref ref-type="bibr" rid="R13">13</xref>]. Additionally, bio-activities as anti-inflammatory [<xref ref-type="bibr" rid="R14">14</xref>], antiplatelet [<xref ref-type="bibr" rid="R15">15</xref>] and immunomodulatory [<xref ref-type="bibr" rid="R16">16</xref>] were demonstrated. Furthermore, other components isolated from the stem bark such as quinovic acids, polyphenols (flavonoids, proanthocyanidins, and tannins), triterpenes, glycosides and saponins were identified by instrumental methods [<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R20">20</xref>].</p>
<p id="P4">The evaluation of natural compounds to inhibit SARS-CoV-2 in preclinical studies might lead to discover new antiviral drugs and for a better understanding of the viral life cycle. Several cell lines such as Human airway epithelial cells, Vero E6 cells, Caco-2 cells, Calu-3 cells, HEK293T cells, and Huh7 cells are considered the best models <italic>in vitro</italic> to determine the antiviral activity against SARS-CoV-2 [<xref ref-type="bibr" rid="R21">21</xref>]. Hence, the investigations of medicinal plants using specially Vero E6 cell to replicate SARS-CoV-2 and given that is highly expressed the ACE -2 receptor, in kidney tissue, some mechanism could be evaluated due to the characteristics of this culture medium.</p>
<p id="P5">Although the pathophysiology of COVID-19 is not completely understood, a severe inflammatory process has been associated with the severity and progression of the disease [<xref ref-type="bibr" rid="R22">22</xref>]. Therefore, the immune activation so far described during the course of the infection as well as the pulmonary injury could be ameliorated by <italic>U. tomentosa</italic> due to its traditional use as anti-inflammatory [<xref ref-type="bibr" rid="R23">23</xref>], in the folk medicine from South America during years.</p>
<p id="P6">Based on its antiviral activity on other ARN virus and our <italic>in-silico</italic> findings against SARS-CoV-2, we assayed the hydroalcoholic extract of <italic>U. tomentosa</italic> stem bark from Peru as potential antiviral agent <italic>in vitro</italic> against this novel coronavirus.</p>
</sec>
<sec id="S2" sec-type="materials | methods">
<label>2</label>
<title>Material and method</title>
<sec id="S3">
<label>2.1</label>
<title>Plant material</title>
<p id="P7">The <italic>U. tomentosa</italic> (Cat’s claw) used in this investigation is dispensed to patients of the Complementary Medicine Service of EsSalud (Social Health Insurance) in Peru for inflammatory disorders. The raw material (stem bark) of <italic>U. tomentosa</italic> was sourced from the Pharmacy Office of EsSalud in Ica, Peru. Next, the stem bark of <italic>U. tomentosa</italic> was transported to the Faculty of Medicine, of the Universidad Nacional Mayor de San Marcos (UNMSM, Lima, Peru) in order to obtain the hydroalcoholic extract.</p>
</sec>
<sec id="S4">
<label>2.2</label>
<title>Obtaining extract from plant material</title>
<p id="P8">One hundred grams of the raw plant material (stem bark) of <italic>U. tomentosa</italic> was powdered and extracted with 700 ml of 70% ethanol at room temperature for 7 days. Then, the extract was evaporated by using rotary evaporation to obtain a desiccated extract, which was stored at 4 °C until further use.</p>
</sec>
<sec id="S5">
<label>2.3</label>
<title>Preparation of stock solution of <italic>U. tomentosa</italic> extract</title>
<p id="P9">One mg of <italic>U. tomentosa</italic> hydroalcoholic extract was suspended in 1mL of DMSO. The solution was maintained at room temperature, protected from light until use. To prepare a working solution, the stock was diluted to 50mg/mL in DMEM supplemented with 2% Fetal Bovine Serum (FBS) (Final concentration DMSO 5%).</p>
</sec>
<sec id="S6">
<label>2.4</label>
<title>Cell lines and virus</title>
<p id="P10">Vero E6 epithelial cell line from <italic>Cercopithecus aethiops</italic> kidney was donated by Instituto Nacional de Salud (INS) (Bogotá, Colombia). Cells were maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented with 2% FBS and 1% Penicillin-Streptomycin. Cultures were maintained at 37°C, with 5% CO<sub>2</sub>. Infections were done with a viral stock produced from a Colombian isolate of SARS-CoV-2 (hCoV-19/Colombia/ANT-UdeA-200325-01/2020).</p>
</sec>
<sec id="S7">
<label>2.5</label>
<title>Cell viability assays</title>
<p id="P11">The viability of Vero E6 in the presence of <italic>U. tomentosa</italic> extract was evaluated using a MTT (4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Briefly, Vero E6 were seeded at cell density of 1.0 × 10<sup>4</sup> cells/well in 96-well plates and incubated for 24 h at 37°C in a humidified 5% CO<sub>2</sub> atmosphere. After, 100 µL of serial dilutions (1:2) of <italic>U. tomentosa</italic> extract ranging from 3.1 to 50 µg/mL were added to each well and incubated for 48 h, at 37°C with 5% CO<sub>2</sub>. After incubation, supernatants were removed, cells were washed twice with Phosphate Buffered Saline (PBS) (Lonza, Rockland, ME, USA) and 30 µL of the MTT reagent (Sigma Aldrich) (2 mg/mL) were added. The plates were incubated for 2 hours at 37°C, with 5 % CO<sub>2</sub>, protected from light. Then, formazan crystals were dissolved by adding 100 µL of pure DMSO to each well. Plates were read in a multiskan GO spectrophotometer (Thermo) at 570 nm. The average absorbance of cells without treatment was considered as 100% of viability. Based on this control the cell viability of each treated well was calculated. The treatment concentration with 50% cytotoxicity (The 50% cytotoxic concentration - CC<sub>50</sub>) was obtained by performing nonlinear regression followed by the construction of a concentration-response curve (GraphPad Prism). For MTT assay, 2 independent experiments with four replicates each experiment were performed (n=8).</p>
</sec>
<sec id="S8">
<label>2.6</label>
<title>Antiviral Assay</title>
<p id="P12">The antiviral activity of <italic>U. tomentosa</italic> extract against SARS-CoV-2 was evaluated with a pre-post strategy where the treatment was added before and after the infection. Briefly, Vero E6 cells were seeded at density of 1.0 × 10<sup>4</sup> cells/well in 96-well plates and incubated for 24 h, at 37°C with 5% CO<sub>2</sub>. After incubation, 50uL of double dilutions of cat’s claw (3.1 – 25 µg/mL) were added to the cell monolayers during 1 h, 37 °C, 5 % CO<sub>2</sub>. Then, the treatment was removed, and cells were infected with SARS-CoV-2 stock at a multiplicity of infection (MOI) of 0.01 in 50uL of DMEM supplemented with 2% FBS. The inoculum was removed 1-hour post infection (h.p.i), replaced by 170 µL of cat’s claw dilutions and incubated for 48 h, at 37 °C with 5 % CO<sub>2</sub>. After, cell culture supernatants were harvested and stored at −80 °C for virus titration by plaque assay and TCID<sub>50</sub> assay. The supernatant of infected cells without treatment was used as infection control. Chloroquine (CQ) at 50 µM was used as positive control for antiviral activity; 2 independent experiments with 3 replicates of each experiment were performed (n=6).</p>
<sec id="S9">
<label>2.6.1</label>
<title>Plaque assay for SARS-CoV-2 quantification</title>
<p id="P13">The capacity of <italic>U. tomentosa</italic> extract to decrease the PFU/mL of SARS-CoV-2 was evaluated by plaque assay on Vero E6 cells. Briefly, 1.0 x 10<sup>5</sup> Vero E6 cells per well were seeded in 24-well plates for 24 h, at 37°C, with 5% CO<sub>2</sub>. Tenfold serial dilutions of the supernatants obtained from the antiviral assay (200uL per well) were added by duplicate on cell monolayers. After incubation during 1h, at 37°C, with 5% CO<sub>2</sub>, the viral inoculum was removed and 1 mL of semi-solid medium (1.5% carboxymethyl-cellulose in DMEM 1X with 2% FBS and 1% Penicillin-Streptomycin) was added to each well. Cells were incubated for 5 days at 37°C, with 5 % CO<sub>2</sub>. Then, cells were washed twice with PBS. After, cells were fixed and stained with 500 uL of 4 % Formaldehyde / 1 % Crystal violet solution for 30 minutes and washed with PBS. Plaques obtained from each condition were counted. The reduction in the viral titer after treatment with each concentration of <italic>U. tomentosa</italic> extract compared to the infection control is expressed as inhibition percentage. Two independent experiments with two replicates of each experiment were performed (n=4).</p>
</sec>
<sec id="S10">
<label>2.6.2</label>
<title>TCID<sub>50</sub> for SARS-CoV-2 quantification</title>
<p id="P14">The capacity of <italic>U. tomentosa</italic> extract to diminish the CPE caused by SARS-CoV-2 on Vero E6 was evaluated by TCID<sub>50</sub> assay. Briefly, 1.2 x 10<sup>4</sup> Vero E6 cells per well were seeded in 96-well plates for 24 h, at 37°C, with 5% CO<sub>2</sub>. Tenfold serial dilutions of the supernatants obtained from the antiviral assay (50 µL per well) were added by quadruplicate on cell monolayers. After 1h incubation, at 37°C with 5% CO<sub>2</sub>, the viral inoculum was removed and replaced by 170 µL of DMEM supplemented with 2% FBS. Cells were incubated for 5 days at 37°C, with 5 % CO<sub>2</sub>. Then, cells were washed twice with PBS, and then fixed and stained with 100 uL/well of 4 % Formaldehyde / 1 % Crystal violet solution for 30 minutes. Cell monolayers were washed with PBS. The number of wells positive for CPE were determined for each dilution (CPE is considered positive when more that 30% of cell monolayer if compromised).</p>
<p id="P15">The viral titer of TCID<sub>50</sub>/mL was calculated based on Spearman-Käerber method. The reduction of viral titer after treatment with each concentration of <italic>U. tomentosa</italic> extract compared to infection control is expressed as inhibition percentage. A control of cells without infection and treatment was included. Two independent experiments with two replicates of each experiment were performed (n=4).</p>
</sec>
</sec>
<sec id="S11">
<label>2.7</label>
<title>Statistical analysis</title>
<p id="P16">The median inhibitory concentration (IC<sub>50</sub>) values represent the concentration of the <italic>U. tomentosa</italic> extract that reduces virus particle production by 50%. The CC<sub>50</sub> values, represent the cat’s claw solution concentration that causes 50 % cytotoxicity. The corresponding dose-response curves were fitted by non-linear regression analysis using a sigmoidal model. The calculated selectivity index (SI) represents the ratio of CC<sub>50</sub> to IC<sub>50</sub>. All data was analyzed with GraphPad Prism (La Jolla, CA, USA) and data are presented as mean ± SEM. Statistical differences were evaluated via Student’s t-test or Mann–Whitney U test, a value of p ≤ 0.05 was considered significant, with *p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001.</p>
</sec>
</sec>
<sec id="S12" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="S13">
<label>3.1</label>
<title>The cell viability assay on Vero E6 cells in the presence of the <italic>U. tomentosa</italic> extract</title>
<p id="P17">The viability of Vero E6 cells in presence of <italic>U. tomentosa</italic> was higher than 90.0 % at concentrations of 25.0 µg/mL or lower, after of 48 h of incubation (<xref ref-type="fig" rid="F1">Figure 1</xref>). Cell viability at 50.0 µg/mL was 17.3 %; for this reason, this concentration was not included in the antiviral assay. The CC<sub>50</sub> calculated for <italic>U. tomentosa</italic> was of 27.1 µg/mL. Chloroquine at 50uM (positive control of inhibition) did not affect the viability of Vero E6 cells (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
</sec>
<sec id="S14">
<label>3.2</label>
<title>The <italic>U. tomentosa</italic> extract inhibited the number of infectious viral particles of SARS-CoV-2</title>
<p id="P18">An inhibition of 92.7 % of SARS-CoV-2 was obtained after the treatment with <italic>U. tomentosa</italic> at 25.0 µg/mL (p&lt;0.0001) by plaque reduction assay (<xref ref-type="fig" rid="F2">Figure 2</xref>). The <italic>U. tomentosa</italic> extract also showed an inhibition of 31.4 % and 34, 9 % of SARS-CoV-2 at 12.5 and 6.3 µg/mL, respectively (<xref ref-type="fig" rid="F2">Figure 2</xref>). An increase of 76.0 % of PFU/mL of SARS-CoV-2 was obtained after the treatment with <italic>U. tomentosa</italic> extract at 3.1 µg/mL (p= 0.02) (<xref ref-type="fig" rid="F2">Figure 2</xref>). The EC<sub>50</sub> calculated to the extract by plaque assay was 6.6 µg/mL (4.89 – 8.85 µg/mL) for a selectivity index of 4.1. Chloroquine (inhibition positive control) showed an inhibition of 100 % of SARS-CoV-2 at 50 µM (p&lt;0.0001) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
</sec>
<sec id="S15">
<label>3.3</label>
<title>The <italic>U. tomentosa</italic> extract reduced the CPE of SARS-CoV-2</title>
<p id="P19">The <italic>U. tomentosa</italic> extract reduced the CPE of the SARS-COV-2 on Vero E6 cells in a 98.6 % (p=0.02), 92.7 % (p=0.03), 63.2 and 60.4 % at 25, 12.5, 6.3 and 3.1 µg/mL, respectively (<xref ref-type="fig" rid="F3">Figure 3</xref>). The EC<sub>50</sub> calculated of <italic>U. tomentosa</italic> extract by TCID<sub>50</sub> assay was 2.57 µg/mL (1.05 – 3.75 µg/mL) for a selectivity index of 10.54. Chloroquine (50 µM) inhibited the CPE of SARS-CoV-2 on Vero E6 in a 100 % (p=0.008) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
</sec>
</sec>
<sec id="S16" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p id="P20">In South America, the second wave of novel coronaviruses might be more aggressive, increasing the mortality rate and new cases [<xref ref-type="bibr" rid="R24">24</xref>]. Medical trials are underway to determine the efficacy of several vaccines against SARS-CoV-2 [<xref ref-type="bibr" rid="R25">25</xref>]. Otherwise, herbal medicines could become a promising option to tackle the ongoing pandemic caused by COVID 19 [<xref ref-type="bibr" rid="R26">26</xref>]. Some plant extracts and phytochemicals were modeled over numerous targets of SARS-CoV-2 by using <italic>in silico</italic> studies, which is the first step in the discovery of new drugs. In China, the use of herbal formulas has been included in the protocol of primary attention in COVID-19 and medical trials were carried out, and promising results to ameliorate the symptoms were demonstrated [<xref ref-type="bibr" rid="R27">27</xref>].</p>
<p id="P21">Our previous study of <italic>U. tomentosa</italic> (cat’s claw) on this novel coronavirus using <italic>in-silico</italic> analysis showed that two possible mechanisms could be involved in the <italic>in vitro</italic> antiviral activity against SARS-CoV-2 observed in this study. These findings revealed that 3CLpro, an essential enzyme for viral replication, showed key molecular interactions with speciophylline, cadambine, and proanthocyanidin B2, with high binding affinities ranging from −8.1 to −9.2 kcal/mol. [<xref ref-type="bibr" rid="R12">12</xref>]. On the other hand, phytochemicals of <italic>U. tomentosa</italic> such as Proanthocyanidin C1, QAG-2, Uncarine F, 3-isodihydrocadambine, and Uncaric acid (docking scores: -8.6; -8.2; -7.1; -7.6 and -7.0 kcal/mol, respectively) showed high binding affinity for the interface of the RBD–ACE-2. In addition, 3-dihydro-cadambine, Proanthocyanidin B4, Proanthocyanidin B2, and Proanthocyanidin C1 (-7.1; -7.2; -7.2 and -7.0 kcal/mol, respectively) had the highest binding score on SARS-CoV-2 spike glycoprotein [<xref ref-type="bibr" rid="R13">13</xref>]. Since Vero E6 cells are commonly used to replicate SARS-CoV-2 due to the high expression level of the ACE-2 receptor and lack the ability to produce interferon [<xref ref-type="bibr" rid="R28">28</xref>], they are the appropriate substrate to explore the antiviral activity of phytochemicals targeting the receptor binding.</p>
<p id="P22">Mechanisms of the antiviral activity of the hydroalcoholic extract of <italic>U. tomentosa</italic>, on other viruses like Dengue (DEN-2), have been elucidated; alkaloids (pentacyclic alkaloids) from <italic>U. tomentosa</italic> induced apoptosis of infected cells and reduced inflammatory mediators such as TNF-α, and IFN-α with similar effects to dexamethasone [<xref ref-type="bibr" rid="R10">10</xref>]. The quinovic acids (33.1-60 μg/mL) inhibited the Vesicular Stomatitis Virus [<xref ref-type="bibr" rid="R29">29</xref>], and the total extract at concentrations less than 15.75 μg/mL inhibited the Herpes Simplex Virus (HSV-1) replication when added to Vero cells at the same time than the virus [<xref ref-type="bibr" rid="R11">11</xref>].</p>
<p id="P23">Here, we demonstrated that <italic>U. tomentosa</italic> also has an antiviral activity <italic>in vitro</italic> against the SARS-CoV-2 with the EC<sub>50</sub> calculated by plaque assay at 6.6 µg/mL (95% CI: 4.89 – 8.85 µg/mL) and by TCID<sub>50</sub> assay at 2.57 µg/mL (95% CI: 1.05 – 3.75 µg/mL). Whilst the CC<sub>50</sub> corresponding to a 50 % cytotoxic effect was 27.1 µg/mL for <italic>U. tomentosa</italic>. In other medicinal plants assayed against SARS-CoV-2, similar antiviral activity was shown; in particular, Echinaforce<sup>®</sup> (an <italic>Echinacea purpurea</italic> preparation) exhibited an antiviral activity at 50 μg/mL [<xref ref-type="bibr" rid="R30">30</xref>]. Liu Shen capsule, a traditional Chinese medicine, inhibited the SARS-CoV-2 replication with an EC<sub>50</sub> value of 0.6024 μg/mL and CC<sub>50</sub> of 4.930 μg/mL [<xref ref-type="bibr" rid="R31">31</xref>]. Likewise, Phillyrin (KD-1), a representative constituent of <italic>Forsythia suspensa</italic> (Thunb.) presented an EC<sub>50</sub> at 63.90 µg/mL and CC<sub>50</sub> of 1959 µg/mL [<xref ref-type="bibr" rid="R32">32</xref>]. Sulfated polysaccharides named RPI-27 and heparin inhibited SARS-CoV-2 <italic>in vitro</italic> with an EC<sub>50</sub> of 8.3 ± 4.6 μg/mL and 36 ± 14 μg/mL, respectively [<xref ref-type="bibr" rid="R33">33</xref>]. In our study, the selectivity index (SI) of the hydroalcoholic extract of <italic>U. tomentosa</italic> was 4.1. In spite of SI is a low value, theoretically having a higher value would be more effective and safer during <italic>in vivo</italic> treatment for a given viral infection. However, there is no evidence of severe toxicity of the <italic>U. tomentosa</italic> and traditionally its use popular in the form of maceration or decoction is safety [<xref ref-type="bibr" rid="R34">34</xref>].</p>
<p id="P24">There is enough evidence that <italic>U. tomentosa</italic> could ameliorate a wide array of symptoms associated with COVID-19, like the severe inflammation characterized by a cytokine storm [<xref ref-type="bibr" rid="R23">23</xref>] causing endothelial dysfunction. According to the antiviral activity of <italic>U. tomentosa</italic> against SARS-CoV-2, several biochemical mechanisms could be involved in each phase of the viral life cycle. As previously reported, <italic>U. tomentosa</italic> could interfere with viral entrance into host cells [<xref ref-type="bibr" rid="R12">12</xref>], affecting viral replication [<xref ref-type="bibr" rid="R13">13</xref>]. Furthermore, ACE-2 receptors, which are expressed in Vero E6 cells could also be blocked by the phytochemicals of <italic>U. tomentosa</italic> during the entrance of SARS-CoV-2 into the host cells and the aforementioned <italic>in-silico</italic> study would confirm our hypothesis [<xref ref-type="bibr" rid="R13">13</xref>].</p>
<p id="P25">Besides, it might control the hyperinflammation, via inhibition of IL-1α, 1β, 17, and TNF-α [<xref ref-type="bibr" rid="R35">35</xref>], reducing oxidative stress [<xref ref-type="bibr" rid="R36">36</xref>], and protecting the endothelial barrier, via inhibition of IL8, which is linked to the induction of permeability [<xref ref-type="bibr" rid="R37">37</xref>]. It also has antithrombotic potential via antiplatelet mechanism and by inhibiting of thrombin [<xref ref-type="bibr" rid="R15">15</xref>]. Furthermore, <italic>U. tomentosa</italic> modulates the immune system by extending lymphocyte survival via an anti-apoptotic mechanism [<xref ref-type="bibr" rid="R38">38</xref>]. It is known that the 3α protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells [<xref ref-type="bibr" rid="R39">39</xref>]; therefore, the phytochemicals found in the hydroalcoholic extract could inhibit this process and protect of the inflammatory cascade. Interestingly, <italic>U. tomentosa</italic> bark extract reduced the lung inflammation produced by ozone in mice [<xref ref-type="bibr" rid="R40">40</xref>].</p>
<p id="P26">Based on our results, <italic>U. tomentosa</italic> is a promising medicinal herb to combat COVID-19, but it is necessary to continue with animal models followed by clinical trials to validate our results in the context of COVID-19 patients. This study is the first approach of <italic>U. tomentosa</italic> against SARS-CoV-2 and we have to explore specific mechanisms of inhibition and propose the main molecules involved with the antiviral activity. As shown in our phytochemical analysis, the presence of groups chemicals determined by LC/MS (UHPLC-ESI+-HRMS-Orbitrap) such as spiroxindole alkaloids, indole glycosides alkaloids, quinovic acid glycosides, and proanthocyanidins, they could be responsible for the described activity. Here, the mechanisms discussed about the hydroalcoholic extract of <italic>U. tomentosa</italic> are only inferred under the mechanisms evaluated in other RNA viruses reported in the literature, and our previous <italic>in-silico</italic> studies demonstrated on the novel coronavirus.</p>
</sec>
<sec id="S17" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p id="P27">
<italic>U. tomentosa</italic> has been widely used as anti-inflammatory and immunomodulatory agent. Previous studies have shown that <italic>U. tomentosa</italic> has a broad spectrum of effects on several RNA viruses. In this study, we demonstrated that hydroalcoholic extract of <italic>U. tomentosa</italic> stem bark exerted an anti-SARS-CoV-2 activity by inhibiting virus replication <italic>in-vitro</italic> using the Vero E6 cell line, which might support to continue this investigation with specific assays <italic>in-vitro</italic>, then animal models and finally validate its clinical use with medical trials. However, further specific <italic>in vitro</italic> assays combined with <italic>in vivo</italic> studies need to be carried out to validate this <italic>in-vitro</italic> finding. Our investigation shows for the first time the antiviral effect of <italic>U. tomentosa</italic> on novel coronavirus (SARS-CoV-2).</p>
</sec>
</body>
<back>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harcourt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tamin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kamili</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sakthivel</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States</article-title>
<source>Emerg Infect Dis</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.3201/EID2606.200516</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jamsransuren</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Suganuma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kazami</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Batkhuu</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Saxifraga spinulosa-derived components rapidly inactivate multiple viruses including SARS-CoV-2</article-title>
<source>Viruses</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.3390/v12070699</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="web">
<collab>World Health Organization</collab>
<article-title>Coronavirus Dis Wkly Epidemiol Updat Wkly Oper Updat 2020</article-title>
<date-in-citation>accessed October 4, 2020</date-in-citation>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poterico</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Mestanza</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Genetic variants and source of introduction of SARS-CoV-2 in South America</article-title>
<source>J Med Virol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.26001</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>C-C</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>T-P</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>W-C</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H-J</given-names>
</name>
<name>
<surname>Hsueh</surname>
<given-names>P-R</given-names>
</name>
</person-group>
<article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</article-title>
<source>Int J Antimicrob Agents</source>
<year>2020</year>
<volume>55</volume>
<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id>
<comment>105924</comment>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="web">
<collab>WHO</collab>
<article-title>WHO supports scientifically-proven traditional medicineNo Title</article-title>
<year>2020</year>
<date-in-citation>accessed October 4, 2020</date-in-citation>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine">https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Oliveira</surname>
<given-names>LZ</given-names>
</name>
<name>
<surname>Farias</surname>
<given-names>ILG</given-names>
</name>
<name>
<surname>Rigo</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Glanzner</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>PBD</given-names>
</name>
<name>
<surname>Cadoná</surname>
<given-names>FC</given-names>
</name>
<etal/>
</person-group>
<article-title>Effect of Uncaria tomentosa extract on apoptosis triggered by oxaliplatin exposure on HT29 cells</article-title>
<source>Evidence-Based Complement Altern Med</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1155/2014/274786</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heitzman</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Neto</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Winiarz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vaisberg</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae)</article-title>
<source>Phytochemistry</source>
<year>2005</year>
<pub-id pub-id-type="doi">10.1016/j.phytochem.2004.10.022</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lock</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Villar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Bioactive compounds from plants used in peruvian traditional medicine</article-title>
<source>Nat Prod Commun</source>
<year>2016</year>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reis</surname>
<given-names>SRIN</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>LMM</given-names>
</name>
<name>
<surname>Sampaio</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Siani</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Gandini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Azeredo</surname>
<given-names>EL</given-names>
</name>
<etal/>
</person-group>
<article-title>Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2</article-title>
<source>Int Immunopharmacol</source>
<year>2008</year>
<pub-id pub-id-type="doi">10.1016/j.intimp.2007.11.010</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caon</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Feltrin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Carvalho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sincero</surname>
<given-names>TCM</given-names>
</name>
<name>
<surname>Ortega</surname>
<given-names>GG</given-names>
</name>
<etal/>
</person-group>
<article-title>Antimutagenic and antiherpetic activities of different preparations from Uncaria tomentosa (cat’s claw)</article-title>
<source>Food Chem Toxicol</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1016/j.fct.2014.01.013</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yepes-Pérez</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Herrera-Calderon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sánchez-Aparicio</surname>
<given-names>J-E</given-names>
</name>
<name>
<surname>Tiessler-Sala</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maréchal</surname>
<given-names>J-D</given-names>
</name>
<name>
<surname>Cardona-G</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Investigating Potential Inhibitory Effect of Uncaria tomentosa (Cat’s Claw) against the Main Protease 3CLpro of SARS-CoV-2 by Molecular Modeling. Evidence-Based Complement</article-title>
<source>Altern Med</source>
<year>2020</year>
<volume>2020</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1155/2020/4932572</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yepes-Pérez</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Herrera-Calderon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Quintero-Saumeth</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Uncaria tomentosa (cat’s claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling</article-title>
<source>J Biomol Struct Dyn</source>
<year>2020</year>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1080/07391102.2020.1837676</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandoval-Chacón</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mannick</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Sadowska-Krowicka</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Antiinflammatory actions of cat’s claw: The role of NF-κB</article-title>
<source>Aliment Pharmacol Ther</source>
<year>1998</year>
<pub-id pub-id-type="doi">10.1046/j.1365-2036.1998.00424.x</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolodziejczyk-Czepas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ponczek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sady-Janczak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pilarski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bukowska</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Extracts from Uncaria tomentosa as antiplatelet agents and thrombin inhibitors – The in vitro and in silico study</article-title>
<source>J Ethnopharmacol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jep.2020.113494</pub-id>
<comment>113494</comment>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenzi</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Campestrini</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Okumura</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Bertol</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ortega</surname>
<given-names>GG</given-names>
</name>
<etal/>
</person-group>
<article-title>Effects of aqueous fractions of Uncaria tomentosa (Willd.) D.C. on macrophage modulatory activities</article-title>
<source>Food Res Int</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1016/j.foodres.2013.02.042</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Navarro-Hoyos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lebrón-Aguilar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Quintanilla-López</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Cueva</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hevia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Quesada</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Proanthocyanidin characterization and bioactivity of extracts from different parts of Uncaria tomentosa L. (cat’s claw)</article-title>
<source>Antioxidants</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.3390/antiox6010012</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dietrich</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rockenbach</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Figueiró</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bergamin</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>da Cunha</surname>
<given-names>FM</given-names>
</name>
<etal/>
</person-group>
<article-title>Quinovic acid glycosides purified fraction from Uncaria tomentosa induces cell death by apoptosis in the T24 human bladder cancer cell line</article-title>
<source>Food Chem Toxicol</source>
<year>2014</year>
<pub-id pub-id-type="doi">10.1016/j.fct.2014.02.037</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aquino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>De Tommasi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>De Simone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pizza</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Triterpenes and quinovic acid glycosides from Uncaria tomentosa</article-title>
<source>Phytochemistry</source>
<year>1997</year>
<pub-id pub-id-type="doi">10.1016/S0031-9422(96)00716-9</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peñaloza</surname>
<given-names>EMC</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Resende</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Pittol</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>ÂR</given-names>
</name>
<name>
<surname>Ortega</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Chemical composition variability in the Uncaria tomentosa (cat’s claw) wild population</article-title>
<source>Quim Nova</source>
<year>2015</year>
<pub-id pub-id-type="doi">10.5935/0100-4042.20150007</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takayama</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>In Vitro and Animal Models for SARS-CoV-2 research</article-title>
<source>Trends Pharmacol Sci</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.tips.2020.05.005</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohn</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sepiashvili</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Steele</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Adeli</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pathophysiology of COVID-19: Mechanisms underlying disease severity and progression</article-title>
<source>Physiology</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1152/physiol.00019.2020</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>AO</given-names>
</name>
<name>
<surname>Polonini</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Dijkers</surname>
<given-names>ECF</given-names>
</name>
</person-group>
<article-title>Postulated Adjuvant Therapeutic Strategies for COVID-19</article-title>
<source>J Pers Med</source>
<year>2020</year>
<volume>10</volume>
<fpage>80</fpage>
<pub-id pub-id-type="doi">10.3390/jpm10030080</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Beware of the second wave of COVID-19</article-title>
<source>Lancet</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30845-X</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabaan</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Al-Ahmed</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Sah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yatoo</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>SK</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic</article-title>
<source>Ann Clin Microbiol Antimicrob</source>
<year>2020</year>
<volume>19</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/s12941-020-00384-w</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19</article-title>
<source>Front Med</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1007/s11684-020-0757-x</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis</article-title>
<source>Pharmacol Res</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.phrs.2020.105056</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogando</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Dalebout</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Zevenhoven-Dobbe</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Limpens</surname>
<given-names>RWAL</given-names>
</name>
<name>
<surname>van der Meer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Caly</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-coronavirus-2 replication in Vero E6 cells: Replication kinetics, rapid adaptation and cytopathology</article-title>
<source>J Gen Virol</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1099/jgv.0.001453</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aquino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>De Simone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pizza</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Plant metabolites. Structure and in vitro antiviral activity of quinovic acid glycosides from uncaria tomentosa and guettarda platypoda</article-title>
<source>J Nat Prod</source>
<year>1989</year>
<pub-id pub-id-type="doi">10.1021/np50064a002</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Signer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jonsdottir</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Albrich</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Strasser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Züst</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ryter</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2</article-title>
<source>Virol J</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1186/s12985-020-01401-2</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway</article-title>
<source>Pharmacol Res</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104850</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway</article-title>
<source>Phytomedicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.phymed.2020.153296</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>S-J</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro</article-title>
<source>Cell Discov</source>
<year>2020</year>
<volume>6</volume>
<fpage>50</fpage>
<pub-id pub-id-type="doi">10.1038/s41421-020-00192-8</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maruoka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kitanaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamaoka</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kameda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Imataki</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>Lemongrass essential oil and citral inhibit Src/Stat3 activity and suppress the proliferation/survival of small-cell lung cancer cells, alone or in combination with chemotherapeutic agents</article-title>
<source>Int J Oncol</source>
<year>2018</year>
<pub-id pub-id-type="doi">10.3892/ijo.2018.4314</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rojas-Duran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>González-Aspajo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ruiz-Martel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bourdy</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Doroteo-Ortega</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Alban-Castillo</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Anti-inflammatory activity of Mitraphylline isolated from Uncaria tomentosa bark</article-title>
<source>J Ethnopharmacol</source>
<year>2012</year>
<pub-id pub-id-type="doi">10.1016/j.jep.2012.07.015</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Jian</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells</article-title>
<source>Food Chem Toxicol</source>
<year>2007</year>
<pub-id pub-id-type="doi">10.1016/j.fct.2007.05.016</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima-Junior</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Da Silva Mello</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kubelka</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Siani</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>LMM</given-names>
</name>
</person-group>
<article-title>Uncaria tomentosa alkaloidal fraction reduces paracellular permeability, il-8 and ns1 production on human microvascular endothelial cells infected with dengue virus</article-title>
<source>Nat Prod Commun</source>
<year>2013</year>
<pub-id pub-id-type="doi">10.1177/1934578X1300801112</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandoval</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Charbonnet</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Okuhama</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krenova</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Trentacosti</surname>
<given-names>AM</given-names>
</name>
<etal/>
</person-group>
<article-title>Cat’s claw inhibits TNFα production and scavenges free radicals: Role in cytoprotection</article-title>
<source>Free Radic Biol Med</source>
<year>2000</year>
<pub-id pub-id-type="doi">10.1016/S0891-5849(00)00327-0</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>PTW</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>TCC</given-names>
</name>
<name>
<surname>Chuck</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>PKS</given-names>
</name>
<etal/>
</person-group>
<article-title>The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells</article-title>
<source>J Gen Virol</source>
<year>2005</year>
<pub-id pub-id-type="doi">10.1099/vir.0.80813-0</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cisneros</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Jayo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Niedziela</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>An Uncaria tomentosa (cat’s claw) extract protects mice against ozone-induced lung inflammation</article-title>
<source>J Ethnopharmacol</source>
<year>2005</year>
<pub-id pub-id-type="doi">10.1016/j.jep.2004.06.039</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Vero E6 cells viability in presence of the <italic>U. tomentosa</italic> extract.</title>
<p>The figure represents the viability percentage of Vero E6 cells after 48h of treatment with <italic>U. tomentosa</italic> (3.1 to 50.0 µg/mL). The viability percentages of treated cell were calculated based on the average absorbance control of cells without treatment. Chloroquine (CQ) was used as inhibition control of the antiviral strategy. Bars represent mean values ± SEM (2 independent experiments with four replicates each experiment were performed, n=8).</p>
</caption>
<graphic xlink:href="EMS104046-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Antiviral activity <italic>in vitro</italic> of <italic>U. tomentosa</italic> extract against SARS-CoV-2 by plaque assay.</title>
<p>
<bold>A</bold>. The figure represents the viral titer (PFU/mL) of supernatants harvested after the treatment with the <italic>U. tomentosa</italic> extract quantified by plaque assay (n=4). Chloroquine (CQ) was used as an inhibition positive control of the antiviral strategy. * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001 <bold>B</bold>. Representative plaques of the antiviral evaluation of the <italic>U. tomentosa</italic> extract against SARS-CoV-2 on Vero E6 cells.</p>
</caption>
<graphic xlink:href="EMS104046-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Antiviral activity <italic>in vitro</italic> of <italic>U. tomentosa</italic> extract against SARS-CoV-2 by TCID<sub>50</sub> assay.</title>
<p>The figure represents the viral titer (TCID<sub>50</sub>/mL) quantified by TCID<sub>50</sub> assay on supernatants harvested from the treatment with the <italic>U. tomentosa</italic> extract (n=4). Chloroquine (CQ) was used as an inhibition positive control of the antiviral strategy. * p ≤ 0.05 and ** p ≤ 0.01 <bold>B</bold>. Representative images of the antiviral evaluation of the <italic>U. tomentosa</italic> extract against SARS-CoV-2 on Vero E6 cells by TCID<sub>50</sub> assay revealed by crystal violet.</p>
</caption>
<graphic xlink:href="EMS104046-f003"/>
</fig>
</floats-group>
</article>
